Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Uniform Quality Standards for a Quarter of a Century

Published: Wednesday, February 27, 2013
Last Updated: Tuesday, February 26, 2013
Bookmark and Share
SCHOTT Tubing has been publishing technical delivery specifications for pharmaceutical tubing for 25 years.

The international technology group SCHOTT has been documenting and publishing technical terms of supply for its glass tubing for use in pharmaceutical applications for 25 years now.

In fact, SCHOTT became the first company in the industry to provide its customers with exact specifications of the most important product parameters in 1988.

Since then, the ongoing improvements that have been made to its special glass tubing used to produce vials, syringes, cartridges and ampoules have been anchored in its terms of supply and thus made visible for its customers.

SCHOTT constantly strives to make improvements that flow into its quality standards to accommodate changing market demands, the needs of its customers and its own goal of providing its customers with maximum benefits.

A revised version of its technical delivery specifications is published about every three years.

“At SCHOTT Tubing, we have been setting the standards on manufacturing glass tubing for 25 years with our technical terms of supply. This means we are committed to constantly improving our production process and offer our customers the highest possible transparency and quality assurance,” says Jürgen Achatz, Global Sales Director for Pharmaceutical Tubing at SCHOTT.

In addition to a description of the products in which all of the characteristics of relevance to its customers are defined in great detail, the technical delivery specifications also include precisely determined tolerance ranges.

SCHOTT’s delivery specifications differ from its competitors’ technical terms of delivery not only in terms of their vast depth of detail and clarity.

The company also subjects its specification to further review by the Federal Association of the German Glass Industry.

The specialized group “Primary Packaging” discusses and evaluates the company’s standards, whereby the results flow directly into the final version of the delivery specifications.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos